Back

Type I Interferon-Driven Monocyte Dysregulation and MAS-associated CD8+ T cells During Macrophage Activation Syndrome

Canny, S. P.; DeBerg, H. A.; Kuan, E. L.; Moss, N.; Gessay, G.; Lu, A.; Huang, A.; O'Rourke, A. R.; Layton, E. D.; Bouvatte, P.; Wittig, P. J.; Speake, C.; Mikacenic, C.; Shenoi, S.; Hui-Yuen, J.; Campbell, D. J.; Barnes, B. J.; Hamerman, J. A.

2026-05-26 immunology
10.64898/2026.05.23.727321 bioRxiv
Show abstract

Macrophage activation syndrome (MAS) is driven by a hyperinflammatory response characterized by aberrant activation of lymphocytes and phagocytes. While monocytes and macrophages are thought to be important in MAS pathogenesis, their role remains poorly understood. We used bulk and single-cell RNA sequencing (RNA-Seq) on sorted monocytes from children with MAS and healthy controls to identify transcriptional changes during MAS. We defined a MAS signature in classical monocytes that correlated with ferritin and was elevated in monocytes from systemic lupus erythematosus and COVID-19 patients. We also identified a subset of classical monocytes with high levels of interferon-stimulated genes (ISGs) that expanded during MAS. Surprisingly, the transcriptional signature of these cells was driven by type I IFNs, rather than IFN{gamma}. Consistent with this finding, we detected increased levels of circulating IFN{beta} during MAS, suggesting that IFN{beta} plays an unrecognized role in driving MAS monocyte responses. We also identified a MAS-associated CD8+ T cell population with a distinctive transcriptional signature. We used cell-cell communication algorithms to predict increased immunoregulatory interactions between monocytes and T cells during MAS. Together, these results provide new evidence for a role for type I IFN during MAS and identify a unique CD8+ T cell population that may contribute to MAS pathophysiology.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Science Translational Medicine
111 papers in training set
Top 0.1%
9.8%
2
Journal of Experimental Medicine
106 papers in training set
Top 0.3%
7.0%
3
Nature Communications
4913 papers in training set
Top 31%
6.1%
4
Immunity
58 papers in training set
Top 1.0%
6.1%
5
Nature Immunology
71 papers in training set
Top 0.4%
4.7%
6
Cell Reports
1338 papers in training set
Top 12%
4.2%
7
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.2%
3.8%
8
Science Immunology
81 papers in training set
Top 0.5%
3.8%
9
Frontiers in Immunology
586 papers in training set
Top 2%
3.5%
10
eLife
5422 papers in training set
Top 28%
3.5%
50% of probability mass above
11
Cell Reports Medicine
140 papers in training set
Top 2%
3.5%
12
Genome Medicine
154 papers in training set
Top 3%
3.0%
13
Leukemia
39 papers in training set
Top 0.4%
3.0%
14
Science
429 papers in training set
Top 11%
2.7%
15
JCI Insight
241 papers in training set
Top 2%
2.5%
16
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 29%
2.0%
17
Cell
370 papers in training set
Top 11%
1.8%
18
Blood
67 papers in training set
Top 0.8%
1.6%
19
The Journal of Immunology
146 papers in training set
Top 0.9%
1.6%
20
Journal of Clinical Investigation
164 papers in training set
Top 3%
1.6%
21
Arthritis & Rheumatology
33 papers in training set
Top 0.3%
1.4%
22
Scientific Reports
3102 papers in training set
Top 67%
1.2%
23
Blood Advances
54 papers in training set
Top 1.0%
1.1%
24
iScience
1063 papers in training set
Top 25%
0.9%
25
PLOS ONE
4510 papers in training set
Top 64%
0.9%
26
Nature
575 papers in training set
Top 15%
0.9%
27
Communications Biology
886 papers in training set
Top 22%
0.8%
28
Frontiers in Genetics
197 papers in training set
Top 9%
0.8%
29
PLOS Pathogens
721 papers in training set
Top 9%
0.7%
30
Life Science Alliance
263 papers in training set
Top 2%
0.7%